Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Chembio DPP™ Micro Reader for use with the DPP Zika IgM Assay System
GSA_VASDP

Catalog No. 23999107
Click to view available options
Quantity:
1
This item is not returnable. View return policy
This item is not returnable. View return policy

Includes

DPP Micro Reader; USB adaptor; RFID sticker; 3 litium ion batteries; DPP catridge holder; microfiber cloth; user manual

DPP Micro Reader is a hand held digital reader for interpreting test results from the DPP Zika IgM System.

  • Portable, hand-held, battery powered digital reader
  • Easy to use, Operates with a single, multi-function button
  • Convenient: a LCD reader displays test results to the operator
  • Maintenance free, non configurable by the end user

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.

Specifications

Content And Storage -20°C to +80°C
Detectable Analytes Antibodies
Format Electronic Reader
For Use With (Application) DPP Zika IgM Assay System
Includes DPP Micro Reader; USB adaptor; RFID sticker; 3 litium ion batteries; DPP catridge holder; microfiber cloth; user manual
Packaging Type Box
Quantity 1

  1. The test has not been FDA cleared or approved
  2. The test has been authorized by FDA under an EUA for use by authorized laboratories
  3. The text has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens
  4. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of the Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.